Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cabotegravir”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05374525
What this trial is testing

A Study Evaluating Implementation Strategies for the Delivery of Cabotegravir in Low and High-Volume PrEP Site in the United States

Who this might be right for
HIV Infections
ViiV Healthcare 287
Not applicableNot Yet RecruitingNCT07390409
What this trial is testing

ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.

Who this might be right for
HIV
Desmond Tutu HIV Foundation 3,700
Not applicableUnknownNCT06319105
What this trial is testing

PathToScale: An Implementation Evaluation

Who this might be right for
Oral Pre-exposure Prophylaxis (PrEP)Long-acting Injectable Cabotegravir for PrEP
Georgetown University 9,900
Early research (Phase 1)Study completedNCT04371380
What this trial is testing

Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants

Who this might be right for
HIV Infections
ViiV Healthcare 15
Early research (Phase 1)Study completedNCT02027454
What this trial is testing

Study to Evaluate the Effect of GSK1265744 on Cardiac Conduction

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 42
Large-scale testing (Phase 3)Active Not RecruitingNCT03299049
What this trial is testing

Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults

Who this might be right for
HIV Infections
ViiV Healthcare 1,049
Early research (Phase 1)Looking for participantsNCT07672717
What this trial is testing

Cabotegravir-Hormone PK/PD Interactions for HIV Prevention

Who this might be right for
HIVProphylaxisInjectable
Johns Hopkins University 32
Early research (Phase 1)Study completedNCT06033547
What this trial is testing

Investigate the Pharmacokinetics, Safety, and Tolerability of Two Different Formulations of Long-acting Cabotegravir in Healthy Adult Participants

Who this might be right for
HIV Infections
ViiV Healthcare 56
Early research (Phase 1)Not Yet RecruitingNCT07818915
What this trial is testing

Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants

Who this might be right for
HIV Infections
ViiV Healthcare 112
Not applicableLooking for participantsNCT06424964
What this trial is testing

Use of Long-Acting Injectable Cabotegravir/Rilpivirine for the Treatment of HIV in Belgium

Who this might be right for
Human Immunodeficiency Virus
Belgian Research on AIDS and HIV Consortium 600
Not applicableLooking for participantsNCT05663580
What this trial is testing

Cohort Study of HIV-positive People, Treated With Long Acting Antiretroviral Therapy

Who this might be right for
HIV Infections
Castagna Antonella 1,500
Early research (Phase 1)Study completedNCT02159131
What this trial is testing

Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects

Who this might be right for
Infections, Human Immunodeficiency Virus and Hepatitis
ViiV Healthcare 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT06133686
What this trial is testing

Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan Africa

Who this might be right for
HIV
MRC/UVRI and LSHTM Uganda Research Unit 400
Large-scale testing (Phase 3)Study completedNCT05917509
What this trial is testing

Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

Who this might be right for
HIV Infections
ViiV Healthcare 171
Large-scale testing (Phase 3)Active Not RecruitingNCT02951052
What this trial is testing

Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 618
Testing effectiveness (Phase 2)Active Not RecruitingNCT06741397
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)

Who this might be right for
HIV Infections
ViiV Healthcare 229
Not applicableStudy completedNCT06643897
What this trial is testing

Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination Cabotegravir+Rilpivirina.

Who this might be right for
HIV-1-infection
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 13
Early research (Phase 1)Study completedNCT02354937
What this trial is testing

Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal Impairment

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 16
Testing effectiveness (Phase 2)Looking for participantsNCT07275606
What this trial is testing

Investigate Cabotegravir for Neonates Exposed to HIV-1

Who this might be right for
HIV Infections
ViiV Healthcare 44
Not applicableActive Not RecruitingNCT07703748
What this trial is testing

Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine.

Who this might be right for
Human Immunodeficiency Virus Infection (HIV)HIV-1 Infection in Adults
FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE 3,346
Next Page